TY - JOUR
T1 - Trajectories of maternal depressive symptoms from pregnancy to 11 years postpartum
T2 - Findings from Avon Longitudinal Study of Parents and Children (ALSPAC) cohort
AU - Mughal, Muhammad Kashif
AU - Giallo, Rebecca
AU - Arshad, Muhammad
AU - Arnold, Paul D.
AU - Bright, Katherine
AU - Charrois, Elyse Mireille
AU - Rai, Baldeep
AU - Wajid, Abdul
AU - Kingston, Dawn
N1 - Funding Information:
The UK Medical Research Council and Wellcome (Grant ref.: 217065/Z/19/Z ) and the University of Bristol provide core support for ALSPAC. This publication is the work of the authors- Dr. Dawn Kingston et al. and will serve as guarantors for the contents of this paper.
Funding Information:
The UK Medical Research Council and Wellcome (Grant ref.: 217065/Z/19/Z) and the University of Bristol provide core support for ALSPAC. This publication is the work of the authors- Dr. Dawn Kingston et al. and will serve as guarantors for the contents of this paper.We are extremely grateful to all the families who took part in this study, the midwives for their help in recruiting them, and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists and nurses. Dr. Mughal work is funded by the Lois Hole Hospital for Women Cross-Provincial Chair in Perinatal Mental Health. Dr. Giallo is supported by the NMRC fellowship. Dr. Arnold holds the Alberta Innovates Translational Health Chair in Child and Youth Mental Health. Dr. Kingston holds a CIHR New Investigator Award and the Lois Hole Hospital for Women Cross-Provincial Chair in Perinatal Mental Health.
Funding Information:
Dr. Mughal work is funded by the Lois Hole Hospital for Women Cross-Provincial Chair in Perinatal Mental Health . Dr. Giallo is supported by the NMRC fellowship. Dr. Arnold holds the Alberta Innovates Translational Health Chair in Child and Youth Mental Health. Dr. Kingston holds a CIHR New Investigator Award and the Lois Hole Hospital for Women Cross-Provincial Chair in Perinatal Mental Health.
Publisher Copyright:
© 2023 Elsevier B.V.
PY - 2023/5/1
Y1 - 2023/5/1
N2 - Background: Maternal depressive symptoms are common in pregnancy and may extend to the perinatal period and beyond for some women. To date, few longitudinal studies have investigated maternal depressive symptoms from pregnancy to eleven years postpartum. Drawing data from a large population-based study cohort the aims of this study were to 1) identify distinct groups of mothers defined by their trajectories of depressive symptoms spanning from pregnancy to eleven years following the birth of the child, and 2) to identify psychosocial risk factors during pregnancy and in the first few postnatal years that are associated with these trajectories. Methods: Data were analyzed from 14,170 mothers who participated in Avon Longitudinal Study of Parents and Children (ALSPAC). The Edinburgh Postnatal Depression Scale (EPDS) was used to capture maternal depressive symptoms across 10 time points including two prenatal (18 and 32 weeks), and eight postnatal (2, 8, 21, 33, 61, 73, 97 and 134 months) time points. The latent growth model was created to describe the course of maternal depressive symptoms across the preceding time points followed by a latent growth mixture modelling (LGMM) to identify distinct trajectories of depressive symptoms over time within the overall sample. The predictors of maternal depressive symptoms trajectories were categorized into sociodemographic, child, and psychosocial factors. The multinomial regression analyses were conducted to explore associations between the risk factors and depressive symptoms trajectories. Results: LGMM identified four distinct trajectories of maternal depressive symptoms over time: minimal symptoms, increasing symptoms, persistent symptoms, and decreasing symptoms. Predictors of all patterns of depression - persistent, increasing and decreasing symptoms include smoking during pregnancy, and partner conflict. The strongest predictors of the persistent symptom trajectory included maternal history of depression and inadequate social support. Limitations: The use of self-reported maternal mental health symptoms and under representation of ethnic minorities are our study's limitations. Conclusions: The study findings highlight the importance of early identification and treatment for mothers experiencing depressive symptoms from pregnancy to the perinatal period and beyond.
AB - Background: Maternal depressive symptoms are common in pregnancy and may extend to the perinatal period and beyond for some women. To date, few longitudinal studies have investigated maternal depressive symptoms from pregnancy to eleven years postpartum. Drawing data from a large population-based study cohort the aims of this study were to 1) identify distinct groups of mothers defined by their trajectories of depressive symptoms spanning from pregnancy to eleven years following the birth of the child, and 2) to identify psychosocial risk factors during pregnancy and in the first few postnatal years that are associated with these trajectories. Methods: Data were analyzed from 14,170 mothers who participated in Avon Longitudinal Study of Parents and Children (ALSPAC). The Edinburgh Postnatal Depression Scale (EPDS) was used to capture maternal depressive symptoms across 10 time points including two prenatal (18 and 32 weeks), and eight postnatal (2, 8, 21, 33, 61, 73, 97 and 134 months) time points. The latent growth model was created to describe the course of maternal depressive symptoms across the preceding time points followed by a latent growth mixture modelling (LGMM) to identify distinct trajectories of depressive symptoms over time within the overall sample. The predictors of maternal depressive symptoms trajectories were categorized into sociodemographic, child, and psychosocial factors. The multinomial regression analyses were conducted to explore associations between the risk factors and depressive symptoms trajectories. Results: LGMM identified four distinct trajectories of maternal depressive symptoms over time: minimal symptoms, increasing symptoms, persistent symptoms, and decreasing symptoms. Predictors of all patterns of depression - persistent, increasing and decreasing symptoms include smoking during pregnancy, and partner conflict. The strongest predictors of the persistent symptom trajectory included maternal history of depression and inadequate social support. Limitations: The use of self-reported maternal mental health symptoms and under representation of ethnic minorities are our study's limitations. Conclusions: The study findings highlight the importance of early identification and treatment for mothers experiencing depressive symptoms from pregnancy to the perinatal period and beyond.
KW - Avon Longitudinal Study of Parents and Children (ALSPAC)
KW - Latent growth mixture modelling (LGMM)
KW - Longitudinal studies
KW - Maternal depressive symptoms
KW - Trajectories
UR - http://www.scopus.com/inward/record.url?scp=85148938890&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85148938890&partnerID=8YFLogxK
U2 - 10.1016/j.jad.2023.02.023
DO - 10.1016/j.jad.2023.02.023
M3 - Article
C2 - 36773763
AN - SCOPUS:85148938890
SN - 0165-0327
VL - 328
SP - 191
EP - 199
JO - Journal of Affective Disorders
JF - Journal of Affective Disorders
ER -